FDA Approves Onivyde Combination for Metastatic Pancreatic Cancer
Approval allows Onivyde (plus oxaliplatin, fluorouracil, and leucovorin) as first-line therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.